Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05662592 · ClinicalTrials.gov registry record · NA
Evaluation of Broadband Light Treatment Protocol for Pigmented Skin Lesions - A Comparative Study
A NA study of Pigmentation, sponsored by Sciton.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT05662592: Completed NA study of Pigmentation, sponsored by Sciton.
NCT05662592 is a NA study of Pigmentation that has completed, run by Sciton. The registered enrollment target is 3 participants, below the 49-participant average among 4 other Pigmentation trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05662592, a NA study of Pigmentation, has completed, sponsored by Sciton.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluation of Broadband Light Treatment Protocols for Pigmented Skin Lesions - A comparative study
Primary Outcome
Change in pigmentation, skin tone and texture will be evaluated using photographs captured at baseline and 4-6 weeks post treatment
Conditions Studied
Interventions
- DEVICE Broadband Light
Study Locations (1)
New Jersey
- New Jersey Plastic Surgery - Montclair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2022-10-01 |
| Est. Completion | 2023-06-06 |
| Phase | NA |
What the finished NCT05662592 record still lists
NCT05662592 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 49-participant average among 4 other Pigmentation trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Pigmentation appearing as the primary indexed condition, and to 1 intervention - of which Broadband Light is the first listed.
NCT05662592 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT05662592 about?
NCT05662592 is a clinical study titled "Evaluation of Broadband Light Treatment Protocol for Pigmented Skin Lesions - A Comparative Study". Evaluation of Broadband Light Treatment Protocols for Pigmented Skin Lesions - A comparative study
What is the current status of trial NCT05662592?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2022-10-01. Estimated completion is 2023-06-06.
What conditions does trial NCT05662592 study?
This clinical trial studies the following conditions: Pigmentation.
What interventions are being tested in trial NCT05662592?
The interventions under investigation include: Broadband Light (DEVICE).
Who is sponsoring clinical trial NCT05662592?
This trial is sponsored by Sciton, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05662592 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pigmentation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles
RECRUITING · NA
-
The Effects of Almond on Facial Skin Collagen and Wrinkles
RECRUITING · NA
-
Evaluation of the Efficacy and Safety of PiQo4 System for the Treatment of Pigmented Lesions
COMPLETED · NA
-
A Study Assessing KB304 for the Treatment of Wrinkles in Women
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI